STOCK TITAN

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Evolent Health (NYSE: EVH) will announce its Q2 2024 financial results on August 8, 2024, post-market close, followed by a conference call at 5 p.m. ET. Interested participants can access the live broadcast via Evolent's investor relations website or join the call by dialing 855.940.9467 (domestic) or 412.317.6034 (international), referencing the 'Evolent call'. An audio playback will be available on the website for 90 days post-call.

Evolent's executive team will also participate in investor conferences, including the Canaccord Genuity 44th Annual Growth Conference in Boston on August 13, 2024, and the 2024 Bernstein Disruptor Conference in New York on September 24, 2024. Webcasts for these events, if available, will be accessible through their investor relations site.

Positive
  • Upcoming release of Q2 2024 financial results on August 8, 2024
  • Active participation in major investor conferences
Negative
  • None.

Company to Participate in Upcoming Conferences

WASHINGTON, July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after market close, with a conference call to follow at 5 p.m. ET.

Shareholders and interested participants may listen to a live broadcast of the conference found on Evolent's investor relations website, https://ir.evolent.com.

Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.

An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.

Upcoming Investor Events

Additionally, The Company announced that its executive management team will participate in upcoming investor conferences.

A live audio-only webcast and replay for these events will be available, if applicable, on the investor relations section of Evolent's website, unless otherwise noted below.

  • Canaccord Genuity 44th Annual Growth Conference at the InterContinental Boston Hotel, Boston, Massachusetts, on August 13, 2024. A live broadcast of management's presentation will take place at 8:30 a.m. ET.
  • 2024 Bernstein Disruptor Conference at the Alliance Bernstein Offices Midtown in New York, New York, on September 24, 2024. A live webcast, if available, will be posted to Evolent's investor relations website.   

About Evolent 

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.

Contacts:

Seth R. Frank
Vice President, Investor Relations
Evolent
sfrank@evolent.com
571-895-3919 (W)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-second-quarter-2024-financial-results-on-thursday-august-8-2024-302194326.html

SOURCE Evolent Health, Inc.

FAQ

When will Evolent Health release its Q2 2024 financial results?

Evolent Health will release its Q2 2024 financial results on August 8, 2024, after market close.

How can I listen to Evolent Health's Q2 2024 financial results conference call?

You can listen to the live broadcast on Evolent's investor relations website or join the call by dialing 855.940.9467 (domestic) or 412.317.6034 (international), referencing the 'Evolent call'.

What events will Evolent Health's executive team participate in?

Evolent Health's executive team will participate in the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, and the 2024 Bernstein Disruptor Conference on September 24, 2024.

Where can I find the replay of Evolent Health's Q2 2024 financial results conference call?

The replay of the conference call will be available on Evolent's investor relations website for 90 days after the call.

What is the stock symbol for Evolent Health?

The stock symbol for Evolent Health is EVH.

Evolent Health, Inc

NYSE:EVH

EVH Rankings

EVH Latest News

EVH Stock Data

3.56B
116.29M
4.03%
115.84%
12.49%
Health Information Services
Services-management Services
Link
United States of America
ARLINGTON